"Anything You Can't Do, I Can't Do Either": Transplantation for High Risk AML

from Journal of Clinical Oncology (JCO) Podcast

This is a commentary on a report from the EBMT demonstrating a higher relapse rate after allogeneic transplantation in AML patients with FLT3 ITD mutations.

Episode metadata supplied by the publisher feed · Published Jan 30, 2012

Embed this episode

Attribution link and audio player

NOW PLAYING

"Anything You Can't Do, I Can't Do Either": Transplantation for High Risk AML

0:00 10:28

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Journal of Clinical Oncology (JCO) Podcast?

This episode is 10 minutes long.

When was this Journal of Clinical Oncology (JCO) Podcast episode published?

This episode was published on January 30, 2012.

Can I download this Journal of Clinical Oncology (JCO) Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!